BioSpace News Archive

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission critical products and services to customers in the life science and advanced technologies & applied materials industries, announced today that it will release its financial results for the second quarter of 2019 on Tuesday, August 6 and will hold a conference call to discuss the results at 8:30 am EDT.

Sales grew 15% to $1.1 billion; underlying1 sales grew 14%

This financing will help fund Ablacon’s first multicenter randomized clinical trial for Ablamap, an advanced mapping system for patients with atrial fibrillation.

Joint venture will initiate drug discovery programs targeting rare diseases using AI

After three decades as an oncology nurse, Janet Soboleski, BSN, RN, OCN, knows that while different cancers have different symptoms and prognoses, virtually all cancer patients experience a sense of isolation.

Bernstein Litowitz Berger & Grossmann LLP announced that it filed a securities class action lawsuit on behalf of its client Allegheny County Employees’ Retirement System against Karyopharm Therapeutics Inc., and certain of the Company’s senior executives, Karyopharm’s Board of Directors, and the underwriters of the Offerings,.

RCCA MSO LLC, the management services entity for Regional Cancer Care Associates LLC and RCCA MD LLC became aware of suspicious activity regarding an employee email account.

Jubilant Cadista Pharmaceuticals Inc. is voluntarily recalling one lot of Drospirenone and Ethinyl Estradiol Tablets, USP, 3 mg/ 0.02mg, 28x3 Blister Pack/Carton to the consumer level.

Seattle Genetics, Inc. announced the pricing of an underwritten public offering of 7,142,858 shares of its common stock at a price to the public of $70.00 per share.

Second quarter 2019 operating results on Tuesday, August 6, 2019 after market close, with a conference call to follow at 5:00 p.m. Eastern Time.